These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37341301)

  • 21. MicroRNA‑144 suppresses aggressive phenotypes of tumor cells by targeting ANO1 in colorectal cancer.
    Jiang Y; Cai Y; Shao W; Li F; Guan Z; Zhou Y; Tang C; Feng S
    Oncol Rep; 2019 Apr; 41(4):2361-2370. PubMed ID: 30816505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer.
    Bill A; Gutierrez A; Kulkarni S; Kemp C; Bonenfant D; Voshol H; Duvvuri U; Gaither LA
    Oncotarget; 2015 Apr; 6(11):9173-88. PubMed ID: 25823819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting inhibition of prognosis-related lipid metabolism genes including CYP19A1 enhances immunotherapeutic response in colon cancer.
    Liu L; Mo M; Chen X; Chao D; Zhang Y; Chen X; Wang Y; Zhang N; He N; Yuan X; Chen H; Yang J
    J Exp Clin Cancer Res; 2023 Apr; 42(1):85. PubMed ID: 37055842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of 14-3-3γ-mediated surface expression of ANO1 inhibits cancer progression of glioblastoma cells.
    Lee YS; Lee JK; Bae Y; Lee BS; Kim E; Cho CH; Ryoo K; Yoo J; Kim CH; Yi GS; Lee SG; Lee CJ; Kang SS; Hwang EM; Park JY
    Sci Rep; 2016 May; 6():26413. PubMed ID: 27212225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of Anoctamin-1 Limits Pulmonary Endothelial Cell Proliferation via p38-Mitogen-activated Protein Kinase-Dependent Apoptosis.
    Allawzi AM; Vang A; Clements RT; Jhun BS; Kue NR; Mancini TJ; Landi AK; Terentyev D; O-Uchi J; Comhair SA; Erzurum SC; Choudhary G
    Am J Respir Cell Mol Biol; 2018 May; 58(5):658-667. PubMed ID: 29100477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of CaMKIIβ Inhibits ANO1-Mediated Glioblastoma Progression.
    Sim KM; Lee YS; Kim HJ; Cho CH; Yi GS; Park MJ; Hwang EM; Park JY
    Cells; 2020 Apr; 9(5):. PubMed ID: 32357567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ferroptosis in cancer immunity and immunotherapy: Multifaceted interplay and clinical implications.
    Zhai X; Lin Y; Zhu L; Wang Y; Zhang J; Liu J; Li L; Lu X
    Cytokine Growth Factor Rev; 2024 Feb; 75():101-109. PubMed ID: 37658030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IFIT1 + neutrophil is a causative factor of immunosuppressive features of poorly cohesive carcinoma (PCC).
    Liu YJ; Li JP; Han M; Li JX; Ye QW; Lin ST; Zhou JY; Liu SL; Zou X
    J Transl Med; 2024 Jun; 22(1):580. PubMed ID: 38898490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promoter hypermethylation as a novel regulator of ANO1 expression and function in prostate cancer bone metastasis.
    Shin Y; Kim S; An W
    Sci Rep; 2024 May; 14(1):11595. PubMed ID: 38773164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced expression of ANO1 in head and neck squamous cell carcinoma causes cell migration and correlates with poor prognosis.
    Ruiz C; Martins JR; Rudin F; Schneider S; Dietsche T; Fischer CA; Tornillo L; Terracciano LM; Schreiber R; Bubendorf L; Kunzelmann K
    PLoS One; 2012; 7(8):e43265. PubMed ID: 22912841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small molecule-facilitated degradation of ANO1 protein: a new targeting approach for anticancer therapeutics.
    Bill A; Hall ML; Borawski J; Hodgson C; Jenkins J; Piechon P; Popa O; Rothwell C; Tranter P; Tria S; Wagner T; Whitehead L; Gaither LA
    J Biol Chem; 2014 Apr; 289(16):11029-11041. PubMed ID: 24599954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anoctamin 1, a multi-modal player in pain and itch.
    Kim H; Shim WS; Oh U
    Cell Calcium; 2024 Nov; 123():102924. PubMed ID: 38964236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developing a machine learning-based prognosis and immunotherapeutic response signature in colorectal cancer: insights from ferroptosis, fatty acid dynamics, and the tumor microenvironment.
    Zhu J; Zhang J; Lou Y; Zheng Y; Zheng X; Cen W; Ye L; Zhang Q
    Front Immunol; 2024; 15():1416443. PubMed ID: 39076986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-glioma effects of 2-aminothiophene-3-carboxamide derivatives, ANO1 channel blockers.
    Choi SH; Ryu S; Sim K; Song C; Shin I; Kim SS; Lee YS; Park JY; Sim T
    Eur J Med Chem; 2020 Dec; 208():112688. PubMed ID: 32906067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel ANO1 Inhibitor from
    Seo Y; Anh NH; Heo Y; Park SH; Kiem PV; Lee Y; Yen DTH; Jo S; Jeon D; Tai BH; Nam NH; Minh CV; Kim SH; Nhiem NX; Namkung W
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High level of ANO1 promotes pancreatic cancer growth in concert with oncogenic KRAS.
    Zhang L; Wang H; Guo J; Xu H; Qian Y; Sun M
    Mol Biol Rep; 2023 Apr; 50(4):3297-3307. PubMed ID: 36715788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance.
    Liu T; Zhu C; Chen X; Guan G; Zou C; Shen S; Wu J; Wang Y; Lin Z; Chen L; Cheng P; Cheng W; Wu A
    Neuro Oncol; 2022 Jul; 24(7):1113-1125. PubMed ID: 35148413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticancer Effect of Hemin through ANO1 Inhibition in Human Prostate Cancer Cells.
    Park SH; Lee Y; Jeon H; Park J; Kim J; Kang M; Namkung W
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring the landscape of drug resistance in gastrointestinal cancer immunotherapy: A review.
    Yao N; Li W; Duan N; Xu G; Yu G; Qu J
    Medicine (Baltimore); 2024 Jan; 103(2):e36957. PubMed ID: 38215151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of novel Ani9 derivatives as potent and selective ANO1 inhibitors.
    Seo Y; Kim J; Chang J; Kim SS; Namkung W; Kim I
    Eur J Med Chem; 2018 Dec; 160():245-255. PubMed ID: 30347323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.